These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35610123)

  • 41. Exploring the impact of gut microbial metabolites on inactivated SARS-CoV-2 vaccine efficacy during pregnancy and mother-to-infant antibody transfer.
    Fu X; Du B; Chen PA; Shama A; Chen B; Zhang X; Han X; Xu Y; Gong Y; Zeng X; Sun C; Yang W; Xing X; Li Z; Fu Y; Ke D; Wang N; Xia Y; Sun Y; Chen Q
    Gut; 2024 Jul; 73(8):1397-1400. PubMed ID: 37739779
    [No Abstract]   [Full Text] [Related]  

  • 42. Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns.
    Cassaniti I; Percivalle E; Zelini P; Ngaradoumbe Nanhorngue K; Parolo A; Bernardi V; Jorizzo G; Santer P; Perotti F; Spinillo A; Lilleri D; Baldanti F
    Clin Microbiol Infect; 2021 Nov; 27(11):1708-1709. PubMed ID: 34371204
    [No Abstract]   [Full Text] [Related]  

  • 43. Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients.
    Chervenak FA; McCullough LB; Bornstein E; Johnson L; Katz A; McLeod-Sordjan R; Nimaroff M; Rochelson BL; Tekbali A; Warman A; Williams K; Grünebaum A
    Am J Obstet Gynecol; 2021 May; 224(5):470-478. PubMed ID: 33539825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy.
    Kumar D; Verma S; Mysorekar IU
    Transl Res; 2023 Jan; 251():84-95. PubMed ID: 35970470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inclusion of pregnant individuals among priority populations for coronavirus disease 2019 vaccination for all 50 states in the United States.
    Grünebaum A; McCullough LB; Litvak A; Chervenak FA
    Am J Obstet Gynecol; 2021 May; 224(5):536-539. PubMed ID: 33545113
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations.
    He Q; Mao Q; Zhang J; Bian L; Gao F; Wang J; Xu M; Liang Z
    Front Immunol; 2021; 12():669339. PubMed ID: 33912196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 vaccine testing in pregnant females is necessary.
    Klein SL; Creisher PS; Burd I
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33444286
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort.
    Geisen UM; Berner DK; Tran F; Sümbül M; Vullriede L; Ciripoi M; Reid HM; Schaffarzyk A; Longardt AC; Franzenburg J; Hoff P; Schirmer JH; Zeuner R; Friedrichs A; Steinbach A; Knies C; Markewitz RD; Morrison PJ; Gerdes S; Schreiber S; Hoyer BF
    Ann Rheum Dis; 2021 Oct; 80(10):1306-1311. PubMed ID: 33762264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 vaccination in pregnancy and postpartum.
    Brillo E; Tosto V; Gerli S; Buonomo E
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6727-6746. PubMed ID: 33998379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 vaccination in pregnancy and postpartum.
    Brillo E; Tosto V; Gerli S; Buonomo E
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7890-7910. PubMed ID: 34154501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022.
    Halasa NB; Olson SM; Staat MA; Newhams MM; Price AM; Boom JA; Sahni LC; Cameron MA; Pannaraj PS; Bline KE; Bhumbra SS; Bradford TT; Chiotos K; Coates BM; Cullimore ML; Cvijanovich NZ; Flori HR; Gertz SJ; Heidemann SM; Hobbs CV; Hume JR; Irby K; Kamidani S; Kong M; Levy ER; Mack EH; Maddux AB; Michelson KN; Nofziger RA; Schuster JE; Schwartz SP; Smallcomb L; Tarquinio KM; Walker TC; Zinter MS; Gilboa SM; Polen KN; Campbell AP; Randolph AG; Patel MM; ;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):264-270. PubMed ID: 35176002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine.
    Beharier O; Plitman Mayo R; Raz T; Nahum Sacks K; Schreiber L; Suissa-Cohen Y; Chen R; Gomez-Tolub R; Hadar E; Gabbay-Benziv R; Jaffe Moshkovich Y; Biron-Shental T; Shechter-Maor G; Farladansky-Gershnabel S; Yitzhak Sela H; Benyamini-Raischer H; Sela ND; Goldman-Wohl D; Shulman Z; Many A; Barr H; Yagel S; Neeman M; Kovo M
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34014840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol.
    Munoz FM; Beigi RH; Posavad CM; Richardson BA; Chu HY; Bok K; Campbell J; Cardemil C; DeFranco E; Frenck RW; Makhene M; Piper JM; Sheffield J; Miller A; Neuzil KM
    BMC Pregnancy Childbirth; 2022 May; 22(1):402. PubMed ID: 35550037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.
    Skjefte M; Ngirbabul M; Akeju O; Escudero D; Hernandez-Diaz S; Wyszynski DF; Wu JW
    Eur J Epidemiol; 2021 Feb; 36(2):197-211. PubMed ID: 33649879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
    Furer V; Eviatar T; Zisman D; Peleg H; Paran D; Levartovsky D; Zisapel M; Elalouf O; Kaufman I; Meidan R; Broyde A; Polachek A; Wollman J; Litinsky I; Meridor K; Nochomovitz H; Silberman A; Rosenberg D; Feld J; Haddad A; Gazzit T; Elias M; Higazi N; Kharouf F; Shefer G; Sharon O; Pel S; Nevo S; Elkayam O
    Ann Rheum Dis; 2021 Oct; 80(10):1330-1338. PubMed ID: 34127481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan.
    Hayakawa S; Komine-Aizawa S; Takada K; Kimura T; Yamada H
    J Obstet Gynaecol Res; 2021 Jun; 47(6):1958-1964. PubMed ID: 33754418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological consideration of COVID-19 infection and vaccines in pregnancy.
    Mohapatra S; Ananda P; Tripathy S
    J Chin Med Assoc; 2022 May; 85(5):537-542. PubMed ID: 35316227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The consequences of COVID-19 and its vaccine on pregnant and lactating mothers.
    Obaid AF; Shlash AMJ; Abdulrasol ZA; Lafta MA
    Egypt J Immunol; 2022 Oct; 29(4):58-74. PubMed ID: 36197154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.